Posts Tagged :

Clinical Outcomes

Treatment Utilization Patterns and Time To Therapy Discontinuation in Patients with ALK+ Metastatic Non-Small Cell Lung Cancer 216 115 Shields Health Solutions

Treatment Utilization Patterns and Time To Therapy Discontinuation in Patients with ALK+ Metastatic Non-Small Cell Lung Cancer

    This poster explores treatment utilization patterns and time to discontinuation (TTD) in patients receiving ALK TKIs for ALK+ mNSCLC.  

Clinical, Safety, and Quality Outcomes of a Hypertrophic Cardiomyopathy Clinical Pharmacy Management Program 216 115 Shields Health Solutions

Clinical, Safety, and Quality Outcomes of a Hypertrophic Cardiomyopathy Clinical Pharmacy Management Program

  This poster evaluates the clinical, safety, and quality outcomes of a pharmacist-led hypertrophic cardiomyopathy (HCM) clinical management program.  

Optimizing Oncology Outcomes: The Impact of Pharmacist-Led Clinical Interventions 70 70 Shields Health Solutions

Optimizing Oncology Outcomes: The Impact of Pharmacist-Led Clinical Interventions

Cancer care is complex. For patients prescribed oral oncolytics, managing side effects, staying on schedule, and coordinating care can be overwhelming. These challenges often lead to missed doses, therapy interruptions,…

The Role of Health System Specialty Pharmacy in Cardiometabolic Disease Care 70 70 Shields Health Solutions

The Role of Health System Specialty Pharmacy in Cardiometabolic Disease Care

Unlock Better Outcomes in Cardiometabolic Disease Care Cardiometabolic disease (CMD) is one of the most pressing healthcare challenges of our time—driving trillions in costs and impacting millions of lives. From diabetes…

Ambulatory Clinical Pharmacist Impact on Coverage Outcomes for Specialty Oncology Medications 216 115 Shields Health Solutions

Ambulatory Clinical Pharmacist Impact on Coverage Outcomes for Specialty Oncology Medications

    This poster evaluates the cimpact of an ACP program on third party pharmacy coverage determination outcomes for specialty oncology medications prescribed from these clinics.  

Clinical, Safety, and Quality Outcomes of a Hypertrophic Cardiomyopathy Clinical Pharmacy Management Program 216 115 Shields Health Solutions

Clinical, Safety, and Quality Outcomes of a Hypertrophic Cardiomyopathy Clinical Pharmacy Management Program

    This poster evaluates the clinical, safety, and quality outcomes of a pharmacist-led HCM clinical management program.  

Analysis of Oral Oncolytic Waste for Patients Filling at a Health System Specialty Pharmacy 216 115 Shields Health Solutions

Analysis of Oral Oncolytic Waste for Patients Filling at a Health System Specialty Pharmacy

    This poster evaluates existing oral oncology medication waste events among patients filling at a HSSP.  

How CHRISTUS Health Reimagined Diabetes Support Through Health System Specialty Pharmacy 70 70 Shields Health Solutions

How CHRISTUS Health Reimagined Diabetes Support Through Health System Specialty Pharmacy
This white paper explores the opportunities and unknowns that health organizations must consider when weighing the implementation of AI.
Analysis of Glucagon-Like Peptide-1 Agonist Trends Within An Integrated Health System Specialty Pharmacy 70 70 Shields Health Solutions

Analysis of Glucagon-Like Peptide-1 Agonist Trends Within An Integrated Health System Specialty Pharmacy

  According to the CDC, approximately 38 million Americans have diabetes (about 1 in 10) and approximately 90-95% of those have type 2 diabetes. GLP-1 and GLP-1/GIP agonists are now recognized…

Shields Outcomes 2024 Report 70 70 Shields Health Solutions

Shields Outcomes 2024 Report
This white paper explores the opportunities and unknowns that health organizations must consider when weighing the implementation of AI.